Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • ETHA vs GSK✓SelectedUSD · GSKETHA vs GSK performance historyLatest closeAs of-3.34%11/13
Stock and ETF performance explorer

ETHA vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
-44.1%
GSK return
+41.8%
Excess return
-85.9%
Maximum drawdown
-67.9%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-3.3%+0.5%-3.9%-3.4%
7D-12.5%+1.1%-13.7%-12.6%
30D-19.8%+6.3%-26.1%-20.1%
3M+3.1%+1.8%+1.3%+3.0%
6M-13.8%+1.7%-15.4%-14.0%
YTD-34.6%+6.5%-41.1%-35.1%
1Y-38.7%+9.5%-48.2%-39.4%
All-44.1%+41.8%-85.9%-53.8%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling